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Vitamin D: Implications of the
Institute of Medicine Report for
Clinical Practice
Dorothy Grasso, RN, MS, CCRN, FNP and Margaret A. Rafferty, DNP, RN, MPH, PMHCNS-BC
In November 2010, the Institute of Medicine (IOM) released Dietary Reference Intakes for
Calcium and Vitamin D, a radical departure from previous advice given regarding these two
nutrients that have been reported in respected health journals. The 14-member expert committee found clear and convincing evidence to support the association between adequate levels of
vitamin D and bone health. The IOM committee did not find enough evidence to support claims
that inadequate levels of vitamin D are linked to increased risks for cancer, cardiovascular
disease, or diabetes. In this article, the authors discuss the controversy surrounding vitamin D
and provide guidance for primary care nurse practitioners.

O

ver the past 15 years, scientists
have produced an impressive
body of evidence highlighting
vitamin D’s central role in maintaining health.1,2 As these dramatic
benefits were reported both in
health journals and the popular
press, many clinicians embraced
the findings by monitoring
patients’ vitamin D serum levels,
encouraging safe sun exposure, and
prescribing supplementation with
vitamin D as needed.2,3 But other
clinicians remained skeptical.4
The purpose of the Institute of
Medicine’s (IOM’s) Dietary Reference
Intakes for Calcium and Vitamin D
report5 was to re-evaluate Dietary
Reference Intakes (DRIs) for vitamin D in light of thousands of
studies published since the last
report in 1997. The IOM report’s
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authors investigated the relationship between calcium and vitamin
D intake and bone health.5 In addition, they ascertained whether low
vitamin D levels might be related to
increased risk for a wide variety of
diseases and conditions, including
cancer, cardiovascular disease, hypertension, diabetes, metabolic syndrome, falls, asthma, inflammatory
bowel disease, Crohn’s disease, multiple sclerosis, rheumatoid arthritis,
systemic lupus erythematosus,
tuberculosis, influenza, upper respiratory infections, autism, cognitive
function, depression, and preeclampsia. Some studies showed that
low vitamin D levels were related to
increased risk for disease, but others
did not show this relationship.
Overall, the evidence was inconclusive in confirming the many
promising hypotheses regarding
the efficacy of vitamin D in preventing a host of health problems.5
In the view of the 14-member
expert panel, evidence from randomized controlled trials (RCTs)
was scant. The report increased the
Recommended Dietary Allowance
(RDA) for vitamin D, set the tolerable Upper Intake Levels, highlighted emerging data pointing to
risks posed by high-dose vitamin D
supplements, and called for standardization of laboratory cutpoints for vitamin D deficiency. To
understand how the IOM reached
its conclusions, it is helpful to look
more closely at the history of
research into the health effects of
vitamin D.

History of Vitamin D Research
Vitamin D and bone health have
attracted scientific interest for
decades.1 Researchers have long
known that vitamin D is essential
to calcium and phosphorus regulation, and that severe deficiencies
result in rickets and osteomalacia.
36
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In the 1980s, epidemiologists
noticed an ominous trend, wherein
persons living at higher latitudes
with less sun exposure seemed to
have higher rates of cancer. As is
well known, exposure to the sun
helps the body produce vitamin D,
which is actually a hormone.6
Might there be a cause-and-effect
relationship between reduced vitamin D levels and cancer risk?
Several long-term observational
studies, known collectively as the
Harvard cohort studies, were used
to investigate the role of vitamin D
in this regard.6 These studies
included the Nurses’ Health Study
I and II, the Health Professional
Follow-Up Study, and the Physicians’ Health Study. These studies
have amassed information about
diet, lifestyle, and incidence of disease over the course of each participant’s lifetime. Blood samples were
collected, enabling investigators to
analyze participants’ vitamin D levels and the incidence of various illnesses. These studies generated a
treasure trove of information,
among which vitamin D’s efficacy
was but one key discovery. The
strongest evidence from the
Harvard cohort studies was the
relationship between decreasing
vitamin D levels and increasing
cancer risk. The Health Professional
Follow-Up Study showed that men
with deficient vitamin D levels were
at increased risk for a myocardial
infarction.7 In toto, data from these
and other studies focused major
attention on vitamin D.
Two extensive reports, Effectiveness and Safety of Vitamin D in
Relation to Bone Health8 and Vitamin
D and Calcium: Systematic Review of
Health Outcomes,9 provided a critical analysis of the vitamin D scientific literature and laid the
groundwork for the 2010 IOM
report. Regarded by many experts

as overly conservative, the thousand-page IOM report has sparked
intense debate.10-12 The Harvard
School of Public Health published
Comment on IOM Vitamin D and
Calcium Recommendations: For Adult
Bone Health, Too Low on Vitamin
D—and Too Generous on Calcium13
on the school’s website, challenging
the IOM’s findings. According to the
Harvard website, the lack of RCTs
did not equate to lack of benefit.
The Endocrine Society released its
own set of clinical guidelines on the
evaluation, treatment, and prevention of vitamin D deficiency.14 The
Endocrine Society task force, comprised of vitamin D experts,
acknowledged the overall low-quality of evidence but expressed hope
that the science would soon
advance and that recommendations
would soon be revised upward.

Incidence of Vitamin D Deficiency
in the US Population
Few patients present with evidence
of severe vitamin D deficiency such
as rickets or hypercalcemia.15
According to the IOM, the cut-point
for identifying vitamin D deficiency
is a serum 25-hydroxyvitamin D
(25OHD) level below 30 nmol/L
(<12 ng/mL).5 A 25OHD level of 50
nmol/L (20 ng/mL) is sufficient to
maintain bone health for most
Americans. The IOM’s cut-points
are much lower than the advice of
other experts, however. The Endocrine Society guidelines defined
vitamin D deficiency as a serum
25OHD level below 50 nmol/L (20
ng/mL) and suggested a minimum
25OHD level of 75 nmol/L (30
ng/mL) to obtain extra-skeletal benefits.14 According to Holick,16 an
expert in the field and lead author
of the Endocrine Society guidelines,
25OHD levels of 52-72 nmol/L (2129 ng/mL) represent insufficiency.
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By these estimates, nearly 1 billion
persons worldwide are vitamin D
deficient.16 According to Ginde et
al,17 who used data from two
National Health and Nutrition
Examination Surveys, the mean
serum 25OHD level in the U.S.
decreased from 30 to 24 ng in a 10year period correlating with campaigns to use sunscreens and avoid
sun exposure.
Older adults, obese individuals,
pregnant or lactating women, persons with pigmented skin, and persons with little or no sun exposure
are at high risk for vitamin D deficiency.15,18 Dark-skinned persons, as
compared with fair-skinned persons, require 5 times as much sun
exposure to produce the same
amount of vitamin D.19 African
Americans, compared with lightskinned populations, have lower
serum 25OHD levels.5 Obesity is
associated with decreased vitamin
D levels because excess fat absorbs
and retains vitamin D, preventing it
from reaching cells and bones.2
Because the ability to synthesize
vitamin D decreases with age, persons older than 60 years require 3-4
times more sun exposure than their
younger counterparts.1,19 Persons
using anticonvulsants, rifampicin,
or highly active antiretroviral drugs
are at high risk for vitamin D deficiency because these drugs induce
the cytochrome P450 enzymes that
metabolize vitamin D.15

Dietary Reference Intakes
The Food and Nutrition Board of
the IOM sets the DRI standard for
nutritional requirements. Components of the DRI include the
estimated average requirement,
RDAs, adequate intake levels, and
tolerable upper intake levels.5
RDAs are used to develop clinical
practice guidelines and to select
doses used in multivitamins and

fortified foods. New DRI values for
vitamin D were released in IOM
report, and are listed in Table 1.5
The increased RDA levels for vitamin D are 600 IU/day for persons
aged 1-70 years and 800 IU/day for
those aged >70 years. The Endocrine Society guidelines regarding
vitamin D adequate intake levels
and upper intake levels differ from
those of the 2010 IOM report (see
references 5 and 14).5,14

of measurement became available.
Vitamin D levels are best represented by serum 25OHD,5 which
is measured by radioimmunoassay, enzyme-linked assays, or liquid chromatography with mass
spectrometry.20
Routine Patient Screening—
According to the 2010 IOM report,5
routine blood screening for vitamin D deficiency is not necessary
because most Americans have adequate vitamin D levels. The
Endocrine Society recommends
screening for vitamin D only in persons at risk for vitamin D deficiency.14 For primary care practitioners
who added assessment of patients’
vitamin D status to their list of preventive health topics years ago, the
new guidelines have been cause for
confusion. Insurance companies
have reacted by stopping payment
or reimbursement for vitamin D
blood testing. On the strength of

Monitoring Vitamin D Levels
Signs and symptoms of vitamin D
deficiency are insidious or nonspecific. As a result, they often go
unrecognized unless blood testing
is done.
Laboratory Testing—According
to the National Institutes of Health
(NIH),18 wide variability in measuring vitamin D existed until July
2009, when a standard reference

TABLE 1

VITAMIN D DIETARY REFERENCE INTAKES BY
LIFE STAGE 5

Age

VITAMIN D
Estimated Average Recommended
Requirement
Dietary Allowance Upper Intake Level
(IU/day)
(IU/day)
(IU/day)

0-6 months

*

*

1000

6-12 months

*

*

1500

1-3 years

400

600

2500

4-8 years

400

600

3000

9-13 years

400

600

4000

14-18 years

400

600

4000

19-30 years

400

600

4000

31-50 years

400

600

4000

51-70 years (males)

400

600

4000

51-70 years (females)

400

600

4000

>70 years

400

800

4000

14-18 years (pregnant/lactating)

400

600

4000

19-50 years (pregnant/lactating)

400

600

4000

*For infants, Adequate Intake is 400 IU/day for those aged 0-6 months and 400 IU/day for those aged 6-12 months.
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the IOM report, some clinicians
have suspended routine vitamin D
screening and recommendations
for vitamin D supplementation.20

Treating and Preventing
Vitamin D Deficiency
The scientific community has not
achieved consensus regarding the
optimal measures needed to treat
or prevent vitamin D deficiency,
which include dietary intake of
vitamin D, sun exposure, and vitamin D supplementation. Table 2
summarizes current guidelines for

TABLE 2

serum 25OHD cut-points, sun
exposure, and supplementation
from a number of prominent academic, professional, and governmental groups.
Diet—The IOM has acknowledged the difficulty of meeting
vitamin D requirements by diet
alone. Few foods naturally contain
vitamin D. Dietary sources of vitamin D include fatty fish (eg, tuna,
salmon, mackerel), egg yolk,
mushrooms, and fish liver oil.18
Most dietary vitamin D in the
United States comes from fortified

foods such as breakfast cereals,
milk, and fruit juices and fruit
drinks. Fortified foods have enough
vitamin D to protect against rickets
and osteomalacia, the most severe
forms of vitamin D deficiency.
Persons with lactose intolerance cannot digest dairy products
and may be at increased risk for
vitamin D deficiency. These individuals can ingest lactose-reduced
dairy products, non-dairy calciumrich foods, calcium supplements,
or lactase pills or drops to meet calcium and vitamin D requirements.

SUMMARY OF GUIDANCE ON VITAMIN D

Guide

Serum 25OHD Cut-points

Sun Exposure

Vitamin D Supplementation

Institute of Medicine (IOM)

Deficiency
30 nmol/L (12 ng/mL)
Inadequacy
30-50 nmol/L (12-20 ng/mL)
Sufficiency
50 nmol/L (20 ng/mL) is all that is
required to maintain bone health
Reason for concern
125 nmol/L (50 ng/mL)*

Calls for investigation of a “minimal-risk
UVB exposure.” The IOM asks, “Is it
possible to create vitamin D synthesis
and avoid skin cancer risk?” The IOM
considered incidental sun exposure
but wants more research on what is a
safe exposure of sun where people
could reap benefits without adverse
effects. The IOM assumed “incidental”
sun exposure in its deliberations.

Report states that most Americans are
not vitamin D deficient and do not require
supplements. Persons who are deficient
and some with inadequacy require
treatment. Supplements recommended for
persons with 25OHD levels <50 nmol/L
(<20 ng/mL).

Endocrine Society14

Deficiency
Less than 50 nmol/L (20 ng/mL)

Harvard School of Public
Health10

Adequate level
75 nmol/L (30 ng/mL)

Does not recommend unprotected
sun exposure.

800-1000 IU/day; some persons may
need 2000 IU/day or more (eg, those with
dark skin, obesity, or little sun exposure).

American Academy of
Dermatology and AAD
Association21

N/A

Recommends protection at all times.

N/A

Holick2,16

Deficiency
Less than 50 nmol/L (20 ng/mL)
Insufficiency
52-72 nmol/L (21-29 ng/mL)
Sufficiency
More than 75 nmol/L (30 ng/mL)
To obtain full benefit for health
100 nmol/L (40 ng/mL)

Recommends sensible sun exposure:
formula based on skin type, latitude,
and season (eg, 10-15 min for a
fair-skinned person between 12 noon
and 2 pm during summertime); see
reference 2 for more details.

Determined by blood level. 1000 IU/day
recommended for non-deficient persons;
total daily intake target is 1500-2000 IU
through all sources (diet, multivitamin,
supplements); see reference 2 for more
details.

International Osteoporosis
Foundation22

Target
75 nmol/L (30 ng/mL) for older
individuals

N/A

Based on blood test results, sun exposure,
body mass index; 2000 IU/day for persons
with obesity, osteoporosis, limited sun
exposure (eg, institutionalized, homebound).

5

Suggests raising blood levels to more
than 75 nmol/L (30 ng/mL) to
obtain possible extra-skeletal benefits.

This table refers to recommendations for adults. It does not cover recommendations for newborns, children, pregnant woman, or persons with other health problems.
*The IOM found good evidence of adverse effects of very high doses of vitamin D.
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Of note, calcium and vitamin D
work effectively only in tandem,
making adequate levels of both
substances essential. Unlike vitamin D, calcium is easily obtained
through dietary sources, although
caffeine intake and medications
such as proton pump inhibitors
can have a negative effect on calcium levels.2
Sun Exposure—Sensible sun
exposure is the most efficient way
to obtain adequate levels of vitamin D.23,24 A few minutes a day of
unprotected sun exposure in the
summer can help maintain adequate levels of vitamin D throughout the year.2 Sunlight includes
ultraviolet A (UVA) light and ultraviolet B (UVB) light, the latter of
which is needed for production of
vitamin D. The degree of success in
obtaining vitamin D from UVB
rays depends on a variety of factors,
including the season, geography,
latitude, time of day, cloud cover,
smog level, amount of melanin
and sunscreen, and mobility and
access to the outdoors. Experts
maintain that generating adequate
levels of vitamin D through sun
exposure is impossible during the
winter months in cities located in
northern latitudes (eg, New York
City, Chicago). In addition, air pollution and glass filter out UVB rays
that urban dwellers depend on for
vitamin D.24
Sensible sun exposure in a fairskinned person can be obtained by
sunbathing without sunscreen for
10-15 minutes between noon and
2 PM during the summer.2 Exposing the face may not even be
necessary or desirable if one’s arms
and legs—25% of the body area—
receive sunlight. Moderation is key.
Any sun exposure causing erythema
(sunburn) is avoided because the
risk for melanoma increases. Many
office workers have schedules that

preclude them from spending any
time in the sun. Increasing their
sun exposure may mean walking
down the sunny side of the street,
eating lunch outside, or making
phone calls from a park bench.
Sun exposure has several
advantages over supplementation
as a source of vitamin D. First, one
cannot “overdose” on vitamin D
through too much exposure to the
sun.2 The body has a natural mechanism to cut off production of vitamin D when a sufficient supply has
been generated. Even severe sunburn will not result in vitamin D
toxicity. Second, the body stores
excess vitamin D in fat and then
releases it during the winter
months when it is needed. Spending the summer in the sun stores
up vitamin D for gray and sunless
winters that effectively halt vitamin
D production.
Experts disagree about sun
exposure. The American Academy
of Dermatology issued a strong
policy statement in 2009 advising
patients to protect themselves
against the sun at all times.21 For
years, the public heeded the advice
of dermatologists to avoid all sun
exposure by using sunscreen and
wearing protective clothing. Companies manufacturing sun-protection products used advertising to
reinforce the medical advice.
Anxious mothers dutifully covered
their children. Persons at risk for
skin cancer (eg, those with a history
of skin cancer, fair-skinned persons
with multiple nevi) conscientiously
avoided all sun exposure until new
research regarding the health benefits of the sun came to light.2 Some
experts have acknowledged that
rates of skin cancer, including
melanoma, rise even with “sensible” sun exposure, but they argue
that the risk is worth taking because
of the overwhelming health bene-

fits of vitamin D.19 Increased skin
cancer screenings are offered as a
possible solution to cope with the
risks of increased sun exposure. The
IOM has identified the need to
research the issue of safe sun exposure to produce vitamin D.
Supplementation—Getting sufficient vitamin D from the sun is
not always possible. Vitamin D
supplements come in two forms,
ergocalciferol (vitamin D2) and
cholecalciferol (vitamin D3). The
efficacy of supplementation is well
documented.2 The Endocrine Society endorses supplementation with
vitamin D2 or vitamin D3.14 Both
the Nutrition Source at the Harvard
School of Public Health and the
International Osteoporosis Foundation endorse using D3 for supplementation.10,22
However, consensus regarding
the recommended daily dose, or
even the need for vitamin D supplementation, does not exist.2,5,20
The IOM does not recommend the
high levels of supplementation
endorsed by many vitamin D
experts.5 In fact, the IOM set 4000
IU/day as the upper tolerable limit
for safety. If a person exceeds a
daily dose of 4000 IU, the possibility of harm increases. The IOM was
clear that “more is not better,” citing emerging evidence that excess
intake of vitamin D is linked to allcause mortality, cancer, cardiovascular risk, falls, and fractures.
Vitamin D supplements are
available over the counter (OTC) at
health food stores, pharmacies,
and grocery stores in strengths
ranging from 400 to 5000 IU.
Multivitamins are another source
of vitamin D. Holick recommends
vitamin D supplements of 10002000 IU/day for most individuals.2
The Nutrition Source at the
Harvard School of Public Health
recommends higher daily doses
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(≥2000 IU) for persons who have
darker skin, spend winters in the
northern U.S., or have little exposure to direct sunlight.10 For persons with severe vitamin D
deficiency, much higher doses are
available by prescription. Vitamin
D toxicity, albeit quite rare, is manifested by nausea, vomiting, poor
appetite, constipation, increased
thirst, depression, increased urination, and/or weight loss.16

Conclusion
The IOM report concluded that the
available current evidence base was
not sufficient to establish causal
links between vitamin D and a
host of diseases and that too much
vitamin D can be harmful.5 The
IOM has outlined a blueprint for
further research to explore the
promising hypotheses that exist
regarding the efficacy of vitamin D.
RCTs with the potential to answer
questions posed by the IOM report
are already in progress. The Vitamin D and Omega-3 Trial (VITAL),
an RCT, began enrolling patients in
January 2010.25 This study, funded
by the NIH, is investigating the role
of dietary vitamin D supplements
or fish oil in reducing risks for cancer, heart disease, and stroke.
Vitamin D has received much
attention because of its numerous
anticancer properties, including
reduced proliferation, invasiveness,
angiogenesis, and metastasis, and
increased differentiation and apoptosis.6,26 Laboratory animal experiments involving the anticancer
properties of vitamin D have provided encouraging results.5
The public health implications
of the vitamin D debates are profound, because inexpensive measures such as sensible sun exposure,
supplementation, and diet can prevent disease worldwide by maintaining and restoring adequate
levels of vitamin D. Practices relat40
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ing to sun avoidance and sun protection appear to have spread, and
have had the unintended consequences with respect to vitamin D
levels, which have plummeted over
the past 30 years.27 Until strict “no
sun” policies were promulgated by
dermatologists starting in the
1970s, most of the public co-existed happily with the sun. From an
evolutionary perspective, the sun
has been and will continue to be
central to human existence.
Nurse practitioners need to
keep pace with the rapid advances
in knowledge of vitamin D. Much
of the data being amassed is
encouraging and useful for engaging patients in a culturally sensitive
dialogue. The outcome of this dialogue must be informed decisions
by patients regarding safe sun
exposure, dietary sources of calcium and vitamin D, and safe supplementation. I
Dorothy Grasso is an assistant professor of nursing at Borough of
Manhattan Community College, City
University of New York. Margaret A.
Rafferty is an associate professor at
New York City College of Technology,
City University of New York. The
authors state that they do not have a
financial interest in or other relationship with any commercial product
named in this article.
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